Lung Cancer Master Protocol (Lung-MAP), a public-private partnership, established infrastructure for conducting a biomarker-driven master protocol in molecularly targeted therapies. We compared ...
Real-world outcomes in patients with metastatic renal cell carcinoma treated with first-line nivolumab plus ipilimumab. Use of formative evaluation surveying and tailored digital education to identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results